Drug Database
AR

aripiprazole (Abilify Maintena / Lu AF41155 / aripiprazole ERIS)

✓ Approved

Otsuka Holdings Co., Ltd. · DRD2 · 小分子

什么是 aripiprazole?

aripiprazole 是一种小分子,由Otsuka Holdings Co., Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名Abilify Maintena, Lu AF41155, aripiprazole ERIS
公司Otsuka Holdings Co., Ltd.
药物类别小分子
分子靶点DRD2, HTR1A, HTR2A
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

作用机制

分子靶点

aripiprazole 作用于 3 个分子靶点:

DRD2dopamine receptor D2 (D2DR, D2R)
HTR1A5-hydroxytryptamine receptor 1A (PFMCD, 5-HT1A)
HTR2A5-hydroxytryptamine receptor 2A (5-HT2A, HTR2)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

aripiprazole 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Psychiatric disordersSchizophrenia✓ Approved
Psychiatric disordersBipolar disorder✓ Approved

相关研究文献

PubMedBMC chemistry2026-11-19

Extractive ion-pair spectrophotometric methods utilizing bromocresol green to estimate chlorpheniramine maleate in pharmaceutical formulations.

Murshed Fatima A FA, Al-Mawri Siham H A SHA, Abdulrahman Sameer A M SAM

Two accurate, sensitive, and cost-effective spectrophotometric methods were developed and validated for the quantitative determination of Chlorpheniramine Maleate (CPM). Method A is based on the formation of a yellow ion-pair complex between CPM and bromocresol green (BCG) in an acidic medium. The resulting complex is extracted into dichloromethane, and its absorbance is measured at 414 nm. Method B involves the dissociation of the yellow-colored CPM-BCG ion-pair complex in a basic medium, leading to the development of a blue color that gives a maximum absorbance at 618 nm. Beer's law was found to be valid within the concentration ranges of 1.00-25.0 µg/mL for method A and 0.20-9.00 µg/mL for method B. The molar absorptivities were determined and found to be 1.76 × 104 and 4.47 × 104 L/(mol.cm) for methods A and B, respectively, with Sandell sensitivity values of 0.0222 and 0.0087 µg/cm². Detection and quantification limits were determined and found to be 0.2049 and 0.6210 µg/mL for method A, and 0.0199 and 0.0603 µg/mL for method B, respectively. The linearity was excellent with correlation coefficients of 0.9995 and 0.9997 for methods A and B. The developed methods were successfully employed to determine CPM in both its pure form and commercial pharmaceutical formulations. The methods were highly precise, with relative standard deviations between 0.24% and 1.85%, and highly accurate, with recovery percentages ranging from 98.14% to 100.8% when applied to pharmaceutical formulations. Statistical comparison with the official USP HPLC method showed no significant differences in accuracy or precision, making the developed methods ideal for routine quality control in resource-limited settings.

PMID 43053190
阅读全文 →
PubMedEssays in biochemistry2026-11-19

The donated chemical probe programme: advancing biomedical research through open science.

Haeberle Sandra S, Tredup Claudia C

Chemical probes enable selective modulation of protein function in live cells, making them valuable tools for studying the roles of proteins in normal and disease physiology. Although initiatives such as the chemical probe development programme at the Structural Genomics Consortium have expanded access to chemial probes for selected target classes, the general availability across the druggable proteome remains limited, particularly for compounds developed within the pharmaceutical industry. The donated chemical probe (DCP) programme addresses this gap through an open-science model that combines unrestricted access to donated probes with comprehensive characterisation data and independent expert review. Since its launch in 2017, the programme has become an important resource for basic as well as translational research. More than 20 organisations have contributed to the initiative, resulting in a collection of about 140 chemical probes together with matched control compounds and previously inaccessible characterisation data that had often remained confined to patents or internal reports. The present review summarises recent developments of the DCP programme and highlights representative examples including case studies such as the BUB1 chemical probe BAY 1816032.

PMID 43053520
阅读全文 →
PubMedFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026-11-19

Chronic Oral Trehalose Intake Induces Sex-Dependent Hippocampal Dysfunction and Cognitive Impairment in Healthy Mice.

Camazzola Davide D, Tomasicchio Barbara B, Serrao Simone S, Pistella Aurora A et al.

Trehalose is a naturally occurring nonreducing disaccharide widely distributed across diverse organisms, where it serves as both a stress protectant and an energy source. Although vertebrates lack the ability to synthesize trehalose, its expanding use in the food, pharmaceutical, and cosmetic industries has led to a marked, unintentional increase in dietary intake. In mammals, trehalose is only partially hydrolyzed, and emerging evidence indicates that a fraction of unmetabolized trehalose can enter systemic circulation, cross the blood-brain barrier, and influence metabolic processes, gut microbiota composition, and potentially brain function. Notably, trehalose has been identified as an inducer of autophagy and has shown efficacy in several models of neurodegenerative diseases. Given its increasing consumption and potential impact on the central nervous system, this study investigates the effects of chronic oral trehalose intake in healthy mice. Using a multidisciplinary approach encompassing behavioral analyses, metabolomics, and ex vivo and in vivo assessments of neuronal function, we demonstrate that prolonged trehalose consumption impairs spatial cognition and associative memory and induces structural, functional, and lipidomic alterations in the brain. These effects exhibit a marked sex-dependent pattern, predominantly affecting male mice. Importantly, these changes occur without significant modulation of autophagy in the brain, suggesting that alternative mechanisms may underlie the observed effects of trehalose on neuronal physiology. Overall, despite its widespread use and GRAS classification, prolonged trehalose intake may adversely affect brain physiology and cognition in a sex-dependent manner.

PMID 43053575
阅读全文 →
PubMedPharmacotherapy2026-11-19

Antiplatelet Use in the Setting of Therapeutic Anticoagulation: A Scoping Review.

Ammar Amina A, Edwin Stephanie B SB, Reed Jason B JB, Kaatz Scott S et al.

Patients receiving therapeutic oral anticoagulation (OAC) often have indications for antiplatelet therapy. Historically, antiplatelet agents have been used alongside therapeutic anticoagulation, increasing the risk of bleeding without a proven reduction in thrombosis. This scoping review summarizes recent evidence evaluating OAC monotherapy compared with combination therapy consisting of OAC plus antiplatelet agent among patients with atrial fibrillation and stable coronary artery disease, cerebrovascular disease, and prosthetic heart valves. We searched PubMed, Embase, CENTRAL, and International Pharmaceutical Abstracts to identify randomized controlled trials (RCTs) evaluating these strategies. Included studies enrolled adults receiving therapeutic anticoagulation across different cardiovascular disease states that reported efficacy and safety outcomes. Two reviewers independently screened studies and extracted data, with disagreements resolved by a third reviewer. Published subgroup analyses of included RCTs were also reviewed. After screening 10,008 records, 11 RCTs met inclusion criteria. Evidence supporting OAC monotherapy was observed in patients with atrial fibrillation and stable coronary artery disease; OAC monotherapy consistently reduced bleeding without increasing ischemic events compared with combination therapy. Similar reductions in bleeding were observed in patients with cerebrovascular disease, although evidence remains limited by small sample size and early trial termination. Among patients undergoing transcatheter aortic valve replacement with an indication for chronic anticoagulation, OAC monotherapy reduced bleeding without compromising ischemic outcomes. Evidence supporting discontinuation of antiplatelet therapy in patients with mechanical heart valves remains limited. Additional RCTs are needed to better define the role of antiplatelet therapy in cerebrovascular disease, prosthetic heart valves, and other high-risk populations.

PMID 43053629
阅读全文 →
PubMedNaunyn-Schmiedeberg's archives of pharmacology2026-11-19

A bibliometric analysis of bibliometric research in pharmacology.

Pathak Manohar M

Bibliometric papers are among the fastest-growing article types in pharmacology, yet the genre itself has seldom been examined with its own tools. We retrieved all Scopus records in the Pharmacology, Toxicology and Pharmaceutics subject area that mentioned 'bibliometric' or 'scientometric' in the title, abstract or keywords (n = 1979; search date 27 October 2026). After a five-step screening procedure that removed errata, duplicate versions and records outside the biomedical and pharmaceutical domain, 1823 documents were analysed. Output grew by 24.5% per year between 2006 and 2025 (doubling time 3.2 years). China-affiliated authors contributed 54.1% of documents but co-authored internationally on only 10.3% of them. Titles framed around 'hotspots', 'frontiers' or 'trends' rose from 9.1% of documents published up to 2020 to 34.4% of those published in 2023-2025, and a formulaic hotspot-plus-mapping title accounted for 29.8% of recent output. Production was concentrated in seven core journals, led by Frontiers in Pharmacology. In a negative binomial model of 913 articles and reviews (2015-2024), review status (incidence rate ratio [IRR] 2.01), international co-authorship (1.64) and acknowledged funding (1.38) were associated with higher citation counts and Chinese language publication with lower counts (0.16). The crude open access advantage (IRR 1.37) disappeared after adjustment for language, and template titles showed no independent association. The model explained only a small share of citation variance, and the associations are observational. The recent expansion of the genre reflects volume more than distinctive impact, which supports asking bibliometric submissions for a pharmacological question, transparent reporting and interpretation beyond descriptive mapping.

PMID 43052392
阅读全文 →
PubMedInternational breastfeeding journal2026-11-19

Breastfeeding outcomes after postpartum haemorrhage: a socio-ecological secondary analysis of the WOMAN trial.

Gilroy James J, O'Connell James J, Cooney Fionnuala F

Breastfeeding has been recognised as a significant driver of neonatal and infant outcomes, particularly in Low- and Middle-income Country (LMIC) settings. Postpartum haemorrhage (PPH) is an increasingly common complication of childbirth, with multiple effects on mothers and their babies. This study aimed to explore the association between aspects of PPH care and outcomes, as they relate to the Socio-Ecological Model of Health for breastfeeding, and the rates of breastfeeding among this cohort of women. This was a secondary analysis of data from the WOMAN trial. The WOMAN trial was a randomised, controlled, pharmaceutical trial in 193 hospitals across 21 countries between 2010 and 2016. A binary logistic regression model was developed to examine the associations between the status of clinical and psycho-social factors from the individual and organisational levels of the Socio-Ecological Model of Health for breastfeeding and the rates of any breastfeeding during the study period. 16,285 mothers of healthy singleton babies were included in the current study. Factors that may result in maternal-infant separation in the immediate postpartum period were associated with lower rates of any breastfeeding in the study period. These included: the mother requiring transfer between hospitals following PPH (Odds Ratio 0.47 [95%CI 0.41-0.54]) and the mother being admitted to ICU postpartum (OR 0.65 [95%CI 0.54-0.78]). Maternal pain (OR 0.65 [95%CI 0.58-0.75]) and maternal anxiety or depression (OR 0.63 [95% CI 0.53-0.75]) were also associated with lower rates of breastfeeding. Some women who experience PPH are at increased risk of not initiating breastfeeding, particularly if there is maternal-infant separation. Organisational factors such as hospital transfer and ICU admission were strongly associated with reduced breastfeeding rates. Individual psycho-social and physical challenges, including pain and psychological distress, further compound these difficulties. Identifying women at higher risk of breastfeeding disruption following PPH could allow targeted support and interventions. Within emergency obstetric care there is a need for universal implementation of breastfeeding-friendly practices, informed by multi-disciplinary, evidence-informed guidelines.

PMID 43053173
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多aripiprazole